Test Price
3,000 AED✅ Home Collection Available
Newborn Genetic Screening Panel (NGS) Test in UAE | 3000 AED | DHA Licensed
Executive Summary & Core Metrics
This newborn genetic screening panel utilises Next Generation Sequencing (NGS) technology to deliver comprehensive coverage of over 100 inborn errors of metabolism and genetic disorders with 99.9% diagnostic sensitivity. Results are available within 3–4 weeks from a single blood sample or FTA card. The test includes telephonic post-test clinical guidance and direct insurance billing verification via WhatsApp.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection — Available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Genetic Counselling included in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS-based newborn screening panel analyses DNA from a single blood spot or FTA card to detect pathogenic variants associated with aminoacidopathies, organic acidurias, fatty acid oxidation defects, urea cycle disorders, and lysosomal storage diseases. The assay achieves single-nucleotide resolution and is processed in an ISO-accredited laboratory under strict quality controls.
| Feature | Our Test (NGS Panel) | Standard Newborn Screening (Tandem MS) |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – genome-wide analysis | Tandem Mass Spectrometry (MS/MS) – targeted metabolite profiling |
| Diagnostic Precision | 99.9% sensitivity; detects variants at single-nucleotide resolution | ~95% sensitivity; limited to predetermined metabolite cutoffs |
| Turnaround Time | 3-4 weeks (comprehensive variant interpretation) | 1-2 weeks (biochemical screening only) |
| Scope of Disorders | Over 100 metabolic and genetic disorders, including rare diseases | Approximately 30–50 common inborn errors of metabolism |
| Post‑Test Support | Telephonic genetic counselling and clinical guidance included | Result report only; counselling often not bundled |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) advises: “As a consultant medical geneticist, I interpret newborn NGS panels within the comprehensive clinical and family context. A positive finding directs targeted confirmatory testing and expedites specialist referral, while a negative result does not exclude all metabolic disorders, particularly if clinical symptoms persist. Genetic counseling is essential before and after testing to ensure informed decision-making and appropriate follow-up.”
Advisory Notice – Medication Safety
⚠️ Important: Do not discontinue or alter any prescribed medication for your infant based solely on genetic screening results. Changes to treatment regimens without physician oversight may precipitate metabolic decompensation or other serious adverse events. Always consult a qualified paediatrician or neonatologist before making any clinical decisions.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Infants with a previously confirmed molecular diagnosis for the same condition; critically ill neonates for whom sample collection would delay urgent life‑sustaining treatment.
- Emergency Red Flags – Seek Immediate Medical Attention: Sudden lethargy, poor feeding, intractable vomiting, seizures, respiratory distress, or hypothermia in a newborn. These may signal an acute metabolic crisis.
Patient FAQ & Clinical Guidance
1. What conditions does this newborn genetic panel screen for?
This NGS panel screens for over 100 metabolic and genetic disorders in newborns, enabling early detection and intervention. Conditions include aminoacidopathies, organic acidurias, fatty acid oxidation defects, urea cycle disorders, and lysosomal storage diseases, all identified through precise DNA sequencing.
2. How is the sample collected for my newborn, and is it safe?
Our VIP mobile phlebotomy team collects a small blood sample from the heel or vein using a sterile, single‑use lancet. The procedure is quick, minimally invasive, and performed by certified paediatric phlebotomists; home collection eliminates hospital stress. Samples can also be applied to a DNA FTA card for easy transport. Collection is available daily from 8 AM to 11 PM.
3. What if the test detects a genetic condition? Will a genetic counsellor help?
A positive result includes a telephonic consultation with a DHA‑licensed genetic counsellor who explains implications, confirmatory testing, and management. Our team coordinates referrals to paediatric metabolic specialists and supports the family through the diagnostic journey, ensuring no parent navigates the results alone.
4. How long does it take to receive the results?
Turnaround time is 3 to 4 weeks from sample receipt. This duration allows for comprehensive sequencing, bioinformatic analysis, variant interpretation, and clinical review by our genetics team to ensure accuracy and reliability of every result.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare information security frameworks. Patient genetic data is handled under:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – governing the collection, processing, and storage of personal health information.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – regulating health data exchange and cybersecurity standards.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – ensuring clinical safety and informed patient consent for all diagnostic procedures.
All genetic reports are encrypted, access-controlled, and retained only as long as necessary for clinical care and legal compliance.
Clinical & Logistical Metadata
| Test Name | Newborn Genetic Screening Panel (NGS) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (heel prick or venipuncture) or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians